The shingles vaccine could decrease risk of dementia by 17%, a new study suggests. University of Oxford researchers found that the Shingrix vaccine is linked to a “significantly” lower risk of dementia in the six years after vaccination than the previously-used Zostavax jab, following a study on more than 200,000Continue Reading

The shingles vaccine could decrease risk of dementia by 17%, a new study suggests. University of Oxford researchers found that the Shingrix vaccine is linked to a “significantly” lower risk of dementia in the six years after vaccination than the previously-used Zostavax jab, following a study on more than 200,000Continue Reading